Find a TenderAwarded
Published 15 Oct 2024, 15:45 BST

Official UK procurement notice

Proprietary Drugs · UK public procurement notice

Official notice

Authority: eTenderwales·Consortium: 2 public authorities

GoodsOpen procedure
Published estimate£392,774,896≈ £131m / year
Submissions closed 15 Nov 2024awarded 27 Jun 2025
Awarded to Abbvie Ltd +9 more10 awards
Contract term 3 yrsends 30 Jun 2028 · extension options published · starts 1 Jul 2025

What is being bought

Published requirement description

Proprietary Drugs

CPV: Pharmaceutical products

The lotProcurement structure

single lot · no lot value published
Lot #1SuppliesAwardedRenewal 3 yrs
Contract period: 1 Jul 2025 – 30 Jun 2028 (3 yrs)
Delivery: UK, Wales
Extensions: There is a possibility to extend up to a further 12 months.Variant bids: allowed

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Price: 170Social value: 15
Published sub-criteria (4)
  • Financial (overall cost of contract): 85
  • Price: 65
  • Price stability: 20
  • Social Value/Community Benefits: 15
Published award criteria (5)
  • Product Quality/Acceptability: Pass/Fail
  • Financial (overall cost of contract): 85
  • Social Value/Community Benefits: 15
  • Price: 65
  • Price stability: 20
Conditions of participation1
  • Suitability

    Any supplier may be disqualified who does not respond to the following in the

    requisite manner:

    1. ENTERING GENERAL Qualification SUPPLIER INFORMATION NHS Wales Shared Services Partnership Procurement Services utilizes Sell2Wales to manage and assess general prequalification information in the form of a profile.

    Candidates are requested to Register company information on the Sell2Wales website at ww.sell2wales.co.uk.

    1. SUBMISSION OF TENDER AND PROCUREMENT SPECIFIC INFORMATION

    (i)Candidates should register on the NHS Wales Shared Services Partnership Procurement Services eTendering portal etenderwales.bravosolution.co.uk/nhs ↗

    (ii) Once registered, candidates must submit their tender as follows a) login to NHS Wales Shared Services Partnership Procurement Services eTendering portal b) select 'Respond to OJEU advert and ITT c) select 'ITTs Open To All Suppliers' d) access listing relating to the contract (title Lenalidomide) and view details e) click on 'Express Interest' button in the 'Actions' box on the left hand side of the page

    (iii) Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation and where you can construct your reply as instructed. You must then publish your reply using the publish button

    (iv) For any support in submitting your tender, please contact the eTendering helpdesk on 08000112470 or at [email protected]

What this means for your bid
  • Price carries 170 of 185 points: a 10% discount moves about 17 points. This one is won on the number: sharpen the price before polishing the prose.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Yes
First published
15 Oct 2024, 15:45 BST
Last source update
28 Jul 2025, 11:04 BST
Award evaluation window
15 Nov 2024 – …
Authority reference
PAD-OJEU-56769
FTS notice number
2025/S 000-043355
Classification (CPV)
Pharmaceutical products
Delivery area
UKWales (UKL)
Official registry OCID
ocds-h6vhtk-04ac47 Find a Tender

Publisher note: 1. The contracting authority reserves the right to use an electronic reverse auction. 2. If and when this requirement is offered for tender, this may be done in whole or in part via electronic means using the internet. 3. The contracting authority is not bound to award a contract in whole or part. 4. The contracting authority will not bear the tender costs of any of the tenderers. 5. In reference to I.1.9 (Variants) to the extent permitted, if at all, in the tender documents. 6. This notice is being placed by NHS Wales Shared Services Partnership – Procurement Services. For the purpose of this procurement, the awarding authority will be Velindre NHS Trust. 7. This advertisement is placed by NHS Wales Shared Services Partnership - Procurement Services on behalf of participating LHB's/Trusts in Wales for the totality of those LHB/Trust specific contractual arrangements. 8. The Framework to be let for 3 years with an option to extend for 12months

How it was run

Official notice
Run through: Jaggaer · Who buys & how to bid on Sell2Wales
Supplier login requiredLanguage: EN
Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail

Tender documents are also served through a separate tool: http://www.etenderwales.bravosolution.co.uk/nhs/ ↗

Submission deadline
15 Nov 2024, 12:00 GMT
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Participation fee
document
Bids opened
15 Nov 2024, 12:01 GMT
Detailed submission instructions & authority contactsFrom official release

Timeline

15 Nov 2024 → 28 Jul 2025 · 4 dates
  1. Submission deadline
    15 Nov 2024, 12:00 GMT
  2. Bids opened
    15 Nov 2024, 12:01 GMT
  3. Contract starts
    1 Jul 2025, 00:00 BST
  4. Notice published
    28 Jul 2025, 11:04 BST

Notice history

2 events · 2 releases on Find a Tender · since 28 Jul 2025
  1. Status changed to complete
    28 Jul 2025, 11:04 BST
  2. Buyer details updated
    28 Jul 2025, 11:04 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 72
Awarded value £111,923,85020 contracts exc. VAT
Bids received 75
Contracts signed 20latest 27 Jun 2025
Awarded toValueDateStatus
Abbvie Ltd£3,883,000 †—Awarded
Astra Zenica£11,689,400 †—Awarded
Baxter Healthcare LtdSME£430,200 †—Awarded
Bayer Plc£46,964,600 †—Awarded
Biogen Idec Ltd£948,600 †—Awarded
Camurus AB£10,585,600 †—Awarded
Chiesi Limited£6,368,400 †—Awarded
Chugai Pharma UK Ltd£310,800 †—Awarded
Cipla EU Limited£138,200 †—Awarded
Colonis Pharma Ltd£11,800 †—Awarded

62 further award records carry no date or value.

Contracts

  • Proprietary Drugs · Abbvie Ltd

    Signed
    27 Jun 2025
    Value
    £3,883,000
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Astra Zenica

    Signed
    17 Jun 2025
    Value
    £11,689,400
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Baxter Healthcare LtdSME

    Signed
    17 Jun 2025
    Value
    £430,200
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Bayer Plc

    Signed
    17 Jun 2025
    Value
    £46,964,600
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Biogen Idec Ltd

    Signed
    17 Jun 2025
    Value
    £948,600
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Camurus AB

    Signed
    17 Jun 2025
    Value
    £10,585,600
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Chiesi Limited

    Signed
    17 Jun 2025
    Value
    £6,368,400
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Chugai Pharma UK Ltd

    Signed
    17 Jun 2025
    Value
    £310,800
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Cipla EU Limited

    Signed
    17 Jun 2025
    Value
    £138,200
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs · Colonis Pharma Ltd

    Signed
    17 Jun 2025
    Value
    £11,800
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £1,298,400
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £1,795,400
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £100,000
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £779,000
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £3,423,200
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £22,355,800
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £32,600
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £41,000
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £331,050
    Period
    … – 30 Jun 2028
    Status
    active
  • Proprietary Drugs

    Signed
    17 Jun 2025
    Value
    £436,800
    Period
    … – 30 Jun 2028
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
75bids———

Contracting authority & participating public bodies

2 public bodies on the notice

eTenderwales

Contracting authorityBody governed by public lawHealth Unit 5 Imperial Park, Celtic Way, Newport, Wales, NP10 8BEContact name, email, phone

Consortium members and other public bodies

Bidders & participating suppliers

72 commercial parties on the notice · 50 awarded

The first 50 of 72 commercial parties (by name); the JSON mirror lists them all.

Show 40 more suppliers

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria
  • Technical selection criteriatenderTechnical selection criteria